VAIA
Virtus Alternative Investment Advisers Portfolio holdings
AUM
$6.71M
This Quarter Return
-15.72%
1 Year Return
+37.54%
3 Year Return
+43.39%
5 Year Return
–
10 Year Return
–
AUM
$7.3M
AUM Growth
+$7.3M
(+9.8%)
Cap. Flow
+$1.72M
Cap. Flow
% of AUM
23.62%
Top 10 Holdings %
Top 10 Hldgs %
33.04%
Holding
275
New
30
Increased
192
Reduced
9
Closed
44
Top Buys
| 1 |
Charter Communications
CHTR
|
$133K |
| 2 |
Comcast
CMCSA
|
$117K |
| 3 |
RTX Corp
RTX
|
$62K |
| 4 |
Cable One
CABO
|
$52.2K |
| 5 |
Altice USA
ATUS
|
$30K |
Top Sells
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$770K |
| 2 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
$742K |
| 3 |
Arrowhead Research
ARWR
|
$12K |
| 4 |
HealthEquity
HQY
|
$11K |
| 5 |
VICI Properties
VICI
|
$10.6K |
Sector Composition
| 1 | Industrials | 18.48% |
| 2 | Healthcare | 16.63% |
| 3 | Technology | 13.11% |
| 4 | Consumer Staples | 6.68% |
| 5 | Communication Services | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Hormel Foods
HRL
$13.9B
| $22K | 0.3% |
470
+263
| +127% | +$12.3K |
|
177
Heartland Express
HTLD
$646M
| $22K | 0.3% |
1,206
+785
| +186% | +$14.3K |
|
178
Skyworks Solutions
SWKS
$10.9B
| $22K | 0.3% |
+247
| New | +$22K |
|
179
Sensient Technologies
SXT
$4.78B
| $22K | 0.3% |
511
+369
| +260% | +$15.9K |
|
180
Allogene Therapeutics
ALLO
$246M
| $21K | 0.29% |
1,101
+777
| +240% | +$14.8K |
|
181
Alarm.com
ALRM
$2.85B
| $21K | 0.29% |
550
+341
| +163% | +$13K |
|
182
Cognex
CGNX
$7.32B
| $21K | 0.29% |
491
+314
| +177% | +$13.4K |
|
183
Chegg
CHGG
$161M
| $21K | 0.29% |
597
+354
| +146% | +$12.5K |
|
184
Clorox
CLX
$15B
| $21K | 0.29% |
124
+64
| +107% | +$10.8K |
|
185
Copart
CPRT
$46.8B
| $21K | 0.29% |
308
+203
| +193% | +$13.8K |
|
186
Cintas
CTAS
$82.1B
| $21K | 0.29% |
124
+90
| +265% | +$15.2K |
|
187
Quest Diagnostics
DGX
$19.9B
| $21K | 0.29% |
265
+180
| +212% | +$14.3K |
|
188
F5
FFIV
$17.5B
| $21K | 0.29% |
201
+139
| +224% | +$14.5K |
|
189
Guidewire Software
GWRE
$18.4B
| $21K | 0.29% |
266
+192
| +259% | +$15.2K |
|
190
Haemonetics
HAE
$2.56B
| $21K | 0.29% |
214
+140
| +189% | +$13.7K |
|
191
HEICO
HEI
$44.1B
| $21K | 0.29% |
288
+221
| +330% | +$16.1K |
|
|
192
HEICO Class A
HEI.A
$34.7B
| $21K | 0.29% |
+333
| New | +$21K |
|
193
Hershey
HSY
$37.4B
| $21K | 0.29% |
162
+102
| +170% | +$13.2K |
|
194
Manhattan Associates
MANH
$12.6B
| $21K | 0.29% |
414
+303
| +273% | +$15.4K |
|
195
Madrigal Pharmaceuticals
MDGL
$9.55B
| $21K | 0.29% |
314
+224
| +249% | +$15K |
|
196
Neurocrine Biosciences
NBIX
$13.8B
| $21K | 0.29% |
244
+166
| +213% | +$14.3K |
|
197
Newmont
NEM
$83.5B
| $21K | 0.29% |
+463
| New | +$21K |
|
198
National Healthcare
NHC
$1.74B
| $21K | 0.29% |
+299
| New | +$21K |
|
199
NVR
NVR
$22.8B
| $21K | 0.29% |
8
+6
| +300% | +$15.8K |
|
200
New York Times
NYT
$9.57B
| $21K | 0.29% |
+700
| New | +$21K |
|